local analgesic effect of subcutaneous ketamine

Preemptive subcutaneous ketamine as a sole agent , does it has a local effect in abdominal gynecological surgeries: A prospective randomized controlled study.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202104461489716

Enrollment

Registered

2021-04-21

Start date

2021-05-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

incisional subcutaneous ketamine

Remote subcutaneous ketamine

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: adult females ASA I or II aging 18-65 years undergoing abdominal gynecological surgery in mansoura university hospital

Exclusion criteria

Exclusion criteria: • Patient refusal • Allergy to used drugs • Addiction • Altered liver or kidney function • Major cardiopulmonary disorder • Uncontrolled hypertension • Psychological problems. • Complicated procedure

Design outcomes

Primary

Measure	Time frame
Total pethedine consumption within the first 24 hours postoperative	—

Secondary

Measure	Time frame
Pain assessment (VAS);HR, MABP;• Gastrointestinal irritation symptoms( nausea, vomiting). • Un-anticipated complication like hallucination, vived dreams.	—

Countries

Egypt

Contacts

Public ContactMOHAMED ABOELELA

lecturer of anesthesia and SICU

aboelela_mohamed@yahoo.com00201061546753

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026